Vident Investment Advisory’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-36,471
Closed -$3.67M 1308
2022
Q3
$3.67M Buy
36,471
+787
+2% +$91.7K 0.12% 205
2022
Q2
$3.15M Sell
35,684
-1,137
-3% -$139K 0.09% 242
2022
Q1
$5.59M Buy
36,821
+1,044
+3% +$194K 0.15% 168
2021
Q4
$11.4M Buy
+35,777
New +$12.6M 0.3% 66

Other funds holding RBOT

Vident Investment Advisory's RBOT Position: Q4 2022 in Review

Vident Investment Advisory sold out of Vicarious Surgical (RBOT) in Q4 2022, closing a stake of 36,471 shares — an estimated $3.67M sold.

Vident Investment Advisory first reported a position in RBOT in Q4 2021 and held it in 4 quarters. The position peaked at $11.4M in Q4 2021. 79 funds tracked by Wall St. Rank hold RBOT as of Q4 2022.

  • Vident Investment Advisory reported no remaining Vicarious Surgical position as of Q4 2022 after selling out during the quarter.
  • Vident Investment Advisory sold 36,471 Vicarious Surgical shares in Q4 2022, an estimated $3.67M.
  • Vident Investment Advisory first reported a position in Vicarious Surgical in Q4 2021 and held it in 4 quarters.
  • Vident Investment Advisory's Vicarious Surgical position peaked at $11.4M in Q4 2021.
  • 79 funds tracked by Wall St. Rank held Vicarious Surgical as of Q4 2022.

Based on Vident Investment Advisory's 13F filing for Q4 2022, filed 14 Feb 2023.